Lpl Financial LLC Regeneron Pharmaceuticals, Inc. Transaction History

Lpl Financial LLC

  • $218 Billion
  • Q3 2024

A detailed history of Lpl Financial LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 49,619 shares of REGN stock, worth $35.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
49,619
Previous 47,242 5.03%
Holding current value
$35.3 Million
Previous $49.7 Million 5.05%
% of portfolio
0.02%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
BUY
$1024.09 - $1201.76 $2.43 Million - $2.86 Million
2,377 Added 5.03%
49,619 $52.2 Million
Q2 2024

Aug 07, 2024
BUY
$883.2 - $1071.19 $5.88 Million - $7.13 Million
6,660 Added 16.41%
47,242 $49.7 Million
Q1 2024

May 10, 2024
SELL
$902.69 - $993.35 $964,975 - $1.06 Million
-1,069 Reduced 2.57%
40,582 $39.1 Million
Q4 2023

Feb 14, 2024
BUY
$775.18 - $881.7 $711,615 - $809,400
918 Added 2.25%
41,651 $36.6 Million
Q3 2023

Nov 13, 2023
BUY
$692.45 - $844.37 $2.41 Million - $2.94 Million
3,479 Added 9.34%
40,733 $33.5 Million
Q2 2023

Jul 31, 2023
BUY
$700.03 - $830.35 $1.22 Million - $1.44 Million
1,736 Added 4.89%
37,254 $26.8 Million
Q1 2023

May 10, 2023
BUY
$680.49 - $826.97 $121,807 - $148,027
179 Added 0.51%
35,518 $29.2 Million
Q4 2022

Feb 07, 2023
BUY
$705.89 - $766.39 $633,183 - $687,451
897 Added 2.6%
35,339 $25.5 Million
Q3 2022

Nov 14, 2022
SELL
$573.97 - $724.32 $379,968 - $479,499
-662 Reduced 1.89%
34,442 $23.7 Million
Q2 2022

Aug 12, 2022
SELL
$548.35 - $738.84 $1.23 Million - $1.65 Million
-2,236 Reduced 5.99%
35,104 $20.8 Million
Q1 2022

May 16, 2022
SELL
$595.12 - $698.43 $933,743 - $1.1 Million
-1,569 Reduced 4.03%
37,340 $26.1 Million
Q4 2021

Feb 14, 2022
BUY
$543.48 - $670.97 $178,261 - $220,078
328 Added 0.85%
38,909 $24.6 Million
Q3 2021

Nov 15, 2021
BUY
$574.03 - $680.96 $2.15 Million - $2.55 Million
3,746 Added 10.75%
38,581 $23.3 Million
Q2 2021

Aug 13, 2021
SELL
$472.8 - $558.54 $2.47 Million - $2.92 Million
-5,222 Reduced 13.04%
34,835 $19.5 Million
Q1 2021

May 14, 2021
BUY
$446.73 - $548.2 $2.17 Million - $2.66 Million
4,849 Added 13.77%
40,057 $19 Million
Q4 2020

Feb 12, 2021
BUY
$478.3 - $607.98 $2.18 Million - $2.77 Million
4,564 Added 14.89%
35,208 $17 Million
Q3 2020

Nov 09, 2020
SELL
$544.75 - $658.21 $1.73 Million - $2.09 Million
-3,173 Reduced 9.38%
30,644 $17.2 Million
Q2 2020

Aug 13, 2020
BUY
$493.32 - $643.92 $2.79 Million - $3.64 Million
5,660 Added 20.1%
33,817 $21.1 Million
Q1 2020

May 14, 2020
BUY
$336.18 - $494.43 $141,531 - $208,155
421 Added 1.52%
28,157 $13.7 Million
Q4 2019

Feb 14, 2020
BUY
$274.13 - $376.51 $563,063 - $773,351
2,054 Added 8.0%
27,736 $10.4 Million
Q3 2019

Nov 13, 2019
SELL
$273.46 - $318.39 $35,002 - $40,753
-128 Reduced 0.5%
25,682 $7.12 Million
Q2 2019

Aug 09, 2019
SELL
$299.6 - $414.82 $1.9 Million - $2.64 Million
-6,356 Reduced 19.76%
25,810 $8.08 Million
Q1 2019

May 08, 2019
BUY
$372.08 - $439.57 $381,754 - $450,998
1,026 Added 3.29%
32,166 $13.2 Million
Q4 2018

Feb 07, 2019
BUY
$335.82 - $403.04 $3.36 Million - $4.04 Million
10,012 Added 47.39%
31,140 $11.6 Million
Q3 2018

Nov 14, 2018
BUY
$351.14 - $408.51 $115,525 - $134,399
329 Added 1.58%
21,128 $8.54 Million
Q2 2018

Aug 14, 2018
BUY
$284.6 - $344.99 $1.43 Million - $1.74 Million
5,030 Added 31.9%
20,799 $7.18 Million
Q1 2018

May 15, 2018
BUY
$315.82 - $393.78 $1.92 Million - $2.39 Million
6,080 Added 62.75%
15,769 $5.43 Million
Q4 2017

Feb 14, 2018
SELL
$358.63 - $469.95 $517,144 - $677,667
-1,442 Reduced 12.95%
9,689 $3.64 Million
Q3 2017

Nov 14, 2017
BUY
$431.38 - $504.0 $1.07 Million - $1.25 Million
2,483 Added 28.71%
11,131 $4.98 Million
Q2 2017

Aug 14, 2017
BUY
N/A
8,648
8,648 $4.25 Million

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.4B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email